Excision of breast fibroepithelial lesions: when is it still necessary?—A 10-year review of a regional centre
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06631-2.pdf
Reference23 articles.
1. Resetkova E, Khazai L, Albarracin CT, Arribas E (2010) Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J 16:573–580. https://doi.org/10.1111/j.1524-4741.2010.01013.x
2. Tan PH, Ellis IO (2013) Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO classification of tumours of the breast 2012. J Clin Pathol 66:465–470. https://doi.org/10.1136/jclinpath-2012-201078
3. Wiratkapun C, Piyapan P, Lertsithichai P, Larbcharoensub N (2014) Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol 20:27–33. https://doi.org/10.5152/dir.2013.13133
4. Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H (2003) Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg 138:987–990. https://doi.org/10.1001/archsurg.138.9.987
5. Marcil G, Wong S, Trabulsi N, Allard-Coutu A, Parsyan A, Omeroglu A, Atinel G, Mesurolle B, Meterissian S (2017) Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors. Am J Surg 214:318–322. https://doi.org/10.1016/j.amjsurg.2016.12.017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized;Breast Cancer Research and Treatment;2024-06-08
2. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO;European Journal of Surgical Oncology;2024-01
3. High-Risk Lesion Management;Seminars in Ultrasound, CT and MRI;2023-02
4. European Guidelines for the Diagnosis, Treatment and Follow-Up of Breast Lesions with Uncertain Malignant Potential (B3 Lesions) Developed Jointly by Eusoma, Eusobi, Esp (Bwg) and Esso;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3